X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (25259) 25259
Book / eBook (75) 75
Magazine Article (61) 61
Book Chapter (23) 23
Newsletter (13) 13
Publication (9) 9
Dissertation (6) 6
Newspaper Article (6) 6
Web Resource (5) 5
Reference (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (23927) 23927
male (16272) 16272
female (12914) 12914
middle aged (12084) 12084
aged (11932) 11932
urinary bladder neoplasms - surgery (11922) 11922
urinary bladder neoplasms - pathology (7927) 7927
urology & nephrology (7446) 7446
adult (6884) 6884
cancer (5383) 5383
bladder cancer (5340) 5340
oncology (4622) 4622
aged, 80 and over (4495) 4495
cystectomy (4275) 4275
treatment outcome (3797) 3797
carcinoma, transitional cell - surgery (3564) 3564
prognosis (3505) 3505
surgery (3457) 3457
retrospective studies (3388) 3388
follow-up studies (3154) 3154
urology (3004) 3004
neoplasm staging (2944) 2944
carcinoma (2776) 2776
urinary bladder neoplasms - drug therapy (2647) 2647
carcinoma, transitional cell - pathology (2630) 2630
bladder (2530) 2530
urinary bladder neoplasms - mortality (2514) 2514
cystectomy - methods (2350) 2350
tumors (2290) 2290
urinary bladder neoplasms - diagnosis (2260) 2260
urinary bladder - surgery (2238) 2238
care and treatment (2186) 2186
neoplasm invasiveness (2175) 2175
radical cystectomy (2105) 2105
urinary bladder neoplasms - therapy (2073) 2073
chemotherapy (1928) 1928
risk factors (1865) 1865
prostatic neoplasms - surgery (1822) 1822
combined modality therapy (1816) 1816
time factors (1799) 1799
survival (1789) 1789
analysis (1788) 1788
urothelial carcinoma (1689) 1689
urinary diversion (1626) 1626
transitional-cell carcinoma (1533) 1533
research (1526) 1526
medicine & public health (1504) 1504
recurrence (1496) 1496
diagnosis (1461) 1461
urinary bladder (1418) 1418
survival rate (1410) 1410
prospective studies (1330) 1330
urinary bladder - pathology (1317) 1317
urinary bladder neoplasms - radiotherapy (1309) 1309
health aspects (1300) 1300
pathology (1265) 1265
urinary bladder neoplasms (1248) 1248
urinary-bladder (1220) 1220
urinary bladder neoplasms - genetics (1197) 1197
disease-free survival (1163) 1163
postoperative complications (1159) 1159
prostatectomy (1152) 1152
animals (1151) 1151
immunohistochemistry (1150) 1150
urinary diversion - methods (1127) 1127
prostate cancer (1120) 1120
bladder-cancer (1106) 1106
radiotherapy (1098) 1098
carcinoma, transitional cell - mortality (1094) 1094
metastasis (1090) 1090
antineoplastic combined chemotherapy protocols - therapeutic use (1075) 1075
neoplasm recurrence, local (1069) 1069
cystoscopy (1059) 1059
urinary bladder neoplasms - metabolism (1020) 1020
complications (1011) 1011
lymphatic metastasis (972) 972
abridged index medicus (954) 954
ureter - surgery (954) 954
outcomes (949) 949
urinary bladder neoplasms - complications (946) 946
administration, intravesical (936) 936
expression (933) 933
quality of life (932) 932
carcinoma, transitional cell - drug therapy (931) 931
transitional-cell-carcinoma (923) 923
survival analysis (916) 916
risk (912) 912
methods (897) 897
management (884) 884
patients (880) 880
chemotherapy, adjuvant (875) 875
therapy (868) 868
disease progression (835) 835
diagnosis, differential (833) 833
mortality (832) 832
prostatic neoplasms - pathology (829) 829
prostate (826) 826
adolescent (822) 822
radiology, nuclear medicine & medical imaging (821) 821
experience (819) 819
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (22) 22
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (11) 11
Online Resources - Online (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
St. Michael's Hospital - Stacks (3) 3
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
Toronto East General Hospital - Online (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21553) 21553
Japanese (1012) 1012
German (956) 956
French (845) 845
Spanish (565) 565
Russian (365) 365
Italian (290) 290
Chinese (277) 277
Polish (73) 73
Bulgarian (58) 58
Hungarian (40) 40
Danish (36) 36
Portuguese (33) 33
Dutch (32) 32
Czech (30) 30
Romanian (29) 29
Swedish (18) 18
Hebrew (17) 17
Norwegian (17) 17
Croatian (13) 13
Turkish (10) 10
Slovak (9) 9
Serbian (7) 7
Ukrainian (5) 5
Lithuanian (4) 4
Afrikaans (3) 3
Finnish (3) 3
Arabic (2) 2
Bosnian (1) 1
Greek (1) 1
Icelandic (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2009, Volume 374, Issue 9685, pp. 239 - 249
Journal Article
The lancet oncology, ISSN 1470-2045, 2013, Volume 14, Issue 9, pp. 863 - 872
Journal Article
World Journal of Urology, ISSN 0724-4983, 4/2014, Volume 32, Issue 2, pp. 475 - 479
Our aim was to assess the effect of surgical wait time on the survival of patients with urological neoplasms, including prostate, bladder, penile, and testicular cancers and upper tract tumours (UTUC... 
Nephrology | Medicine & Public Health | Urology/Andrology | Renal cell carcinoma | Surgery | Oncology | Urothelial carcinoma | Waiting time | Survival | Prostate cancer | BLADDER-CANCER | SMALL RENAL MASSES | MANAGEMENT | RADICAL PROSTATECTOMY | SURVEILLANCE | UROLOGY & NEPHROLOGY | CYSTECTOMY | QUALITY-OF-LIFE | DELAY | Carcinoma, Transitional Cell - mortality | Penile Neoplasms - diagnosis | Prostatectomy - methods | Testicular Neoplasms - mortality | Urologic Neoplasms - diagnosis | Urinary Bladder Neoplasms - diagnosis | Humans | Carcinoma, Renal Cell - surgery | Male | Prostatic Neoplasms - diagnosis | Neoplasms, Germ Cell and Embryonal - diagnosis | Nephrectomy - methods | Kidney Neoplasms - diagnosis | Testicular Neoplasms - surgery | Kidney Neoplasms - surgery | Time Factors | Neoplasms, Germ Cell and Embryonal - mortality | Penile Neoplasms - mortality | Testicular Neoplasms - diagnosis | Urinary Bladder Neoplasms - mortality | Prostatic Neoplasms - surgery | Time-to-Treatment | Urologic Neoplasms - mortality | Carcinoma, Transitional Cell - diagnosis | Kidney Neoplasms - mortality | Urinary Bladder Neoplasms - surgery | Prostatic Neoplasms - mortality | Carcinoma, Renal Cell - mortality | Penile Neoplasms - surgery | Carcinoma, Renal Cell - diagnosis | Ureteral Neoplasms - diagnosis | Neoplasms, Germ Cell and Embryonal - surgery | Carcinoma, Transitional Cell - surgery | Ureteral Neoplasms - mortality | Ureteral Neoplasms - surgery | Cystectomy - methods | Orchiectomy - methods | Urologic Neoplasms - surgery | Diagnosis | Health aspects | Tumors
Journal Article
Japanese journal of clinical oncology, ISSN 1465-3621, 2016, Volume 46, Issue 6, pp. 497 - 501
.... According to the 2015 National Central Cancer Registry (NCCR) of China, the incidence of bladder cancer and prostate cancer ranked sixth and seventh, respectively, in male cancers... 
Treatment | Diagnosis | Bladder cancer | Kidney cancer | Prostrate cancer | kidney cancer | MORTALITY | treatment | prostrate cancer | ONCOLOGY | bladder cancer | diagnosis | RADICAL PROSTATECTOMY | OUTCOMES | METASTATIC PROSTATE-CANCER | Carcinoma, Transitional Cell - mortality | Penile Neoplasms - diagnosis | Testicular Neoplasms - mortality | Kidney Neoplasms - epidemiology | Urologic Neoplasms - diagnosis | Carcinoma, Transitional Cell - epidemiology | Urinary Bladder Neoplasms - diagnosis | Humans | Male | Testicular Neoplasms - epidemiology | Prostatic Neoplasms - diagnosis | Kidney Neoplasms - diagnosis | Penile Neoplasms - epidemiology | Urologic Neoplasms - pathology | China | Urinary Bladder Neoplasms - pathology | Urinary Bladder Neoplasms - epidemiology | Penile Neoplasms - mortality | Prostatic Neoplasms - pathology | Testicular Neoplasms - diagnosis | Urinary Bladder Neoplasms - mortality | Carcinoma, Renal Cell - pathology | Carcinoma, Transitional Cell - diagnosis | Kidney Neoplasms - mortality | Prostatic Neoplasms - mortality | Prostatic Neoplasms - epidemiology | Carcinoma, Renal Cell - mortality | Carcinoma, Renal Cell - epidemiology | Carcinoma, Transitional Cell - pathology | Carcinoma, Renal Cell - diagnosis | Kidney Neoplasms - pathology | Urologic Neoplasms - surgery
Journal Article
Cancer immunology, immunotherapy, ISSN 1432-0851, 2006, Volume 56, Issue 8, pp. 1173 - 1182
The programmed death-1 (PD-1)/B7-H1 (also called PD-L1) pathway negatively regulates T cell activation and has been suggested to play an important role in... 
Urothelial cancer | Biomedicine | Immunology | B7-H1/PD-L1 | Costimulation | T cell | Oncology | Cancer Research | Antitumor immunity | PD-1 | BLADDER-CANCER | DENDRITIC CELLS | PROGRAMMED DEATH-1 | urothelial cancer | TISSUE INFILTRATING LYMPHOCYTES | IMMUNOLOGY | antitumor immunity | POTENTIAL MECHANISM | RENAL-CELL CARCINOMA | CD8(+) T-CELLS | costimulation | ONCOLOGY | PD-L1 | B7 FAMILY | B7-H1 | EXPRESSION | Carcinoma, Transitional Cell - mortality | Prognosis | Antigens, CD - biosynthesis | Humans | Neoplasm Proteins - physiology | Gene Expression Regulation, Neoplastic | Kidney Pelvis - chemistry | Ureteral Neoplasms - pathology | Male | Kidney Neoplasms - chemistry | Antigens, CD - genetics | Antigens, CD - analysis | Kidney Neoplasms - surgery | Urinary Bladder Neoplasms - pathology | Female | Neoplasm Proteins - genetics | Kidney Pelvis - surgery | Urinary Bladder Neoplasms - mortality | B7-H1 Antigen | Neoplasm Proteins - biosynthesis | Ureteral Neoplasms - chemistry | Neoplasm Recurrence, Local | Proportional Hazards Models | Kidney Pelvis - pathology | Immunophenotyping | Kidney Neoplasms - mortality | Urinary Bladder Neoplasms - surgery | Carcinoma, Transitional Cell - pathology | Lymphocytes, Tumor-Infiltrating - pathology | Carcinoma, Transitional Cell - chemistry | Survival Analysis | Antigens, CD - physiology | Kidney Neoplasms - pathology | Neoplasm Proteins - analysis | Urinary Bladder Neoplasms - chemistry | Carcinoma, Transitional Cell - surgery | Ureteral Neoplasms - mortality | Ureteral Neoplasms - surgery | Lymphocytes, Tumor-Infiltrating - immunology | Cancer
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 78, Issue 1, pp. 127 - 135
...% confidence interval [CI], 1.03–2.05), colon (O/E = 1.16; CI, 1.09–1.24), vagina (O/E = 2.71; CI, 1.86–3.8), and urinary bladder... 
Radiology | Hematology, Oncology and Palliative Medicine | Radiation-induced malignancies | HNPCC | Endometrial cancer | Second primary malignancies | SURGERY | LYNCH-SYNDROME | NONPOLYPOSIS COLORECTAL-CANCER | 2ND PRIMARY CANCERS | RISK | CERVICAL-CANCER | RADIATION-THERAPY | UTERINE | ONCOLOGY | OVARIAN | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | United States - epidemiology | Colonic Neoplasms - genetics | Follow-Up Studies | Humans | Middle Aged | Bone Neoplasms - epidemiology | Pharyngeal Neoplasms - etiology | Esophageal Neoplasms - epidemiology | Incidence | Vaginal Neoplasms - genetics | Young Adult | Neoplasms, Radiation-Induced - genetics | Endometrial Neoplasms - genetics | Lung Neoplasms - etiology | Aged, 80 and over | Intestine, Small - radiation effects | Bone Neoplasms - genetics | Neoplasms, Second Primary - genetics | Mouth Neoplasms - genetics | SEER Program | Risk Assessment | Vaginal Neoplasms - etiology | Mouth Neoplasms - etiology | Neoplasms, Second Primary - epidemiology | Mouth Neoplasms - epidemiology | Pharyngeal Neoplasms - genetics | Vaginal Neoplasms - epidemiology | Adolescent | Pharyngeal Neoplasms - epidemiology | Endometrial Neoplasms - radiotherapy | Esophageal Neoplasms - etiology | Age Factors | Neoplasms, Radiation-Induced - etiology | Urinary Bladder Neoplasms - genetics | Adult | Female | Intestinal Neoplasms - genetics | Urinary Bladder Neoplasms - epidemiology | Colonic Neoplasms - etiology | Lung Neoplasms - genetics | Urinary Bladder Neoplasms - etiology | Colonic Neoplasms - epidemiology | Intestinal Neoplasms - etiology | Intestinal Neoplasms - epidemiology | Bone Neoplasms - etiology | Neoplasms, Second Primary - etiology | Lung Neoplasms - epidemiology | Esophageal Neoplasms - genetics | Aged | Neoplasms, Radiation-Induced - epidemiology | Genetic aspects | Research | Oncology, Experimental | Cancer | Index Medicus | LARGE INTESTINE | GASTROINTESTINAL TRACT | ORAL CAVITY | ESOPHAGUS | DIGESTIVE SYSTEM | LUNGS | MEDICINE | PHARYNX | THERAPY | RADIOLOGY AND NUCLEAR MEDICINE | BLADDER | RADIOTHERAPY | RADIOLOGY | SMALL INTESTINE | NEOPLASMS | UTERUS | INTESTINES | NUCLEAR MEDICINE | FEMALE GENITALS | ORGANS | URINARY TRACT | DISEASES | RESPIRATORY SYSTEM | BRACHYTHERAPY | BODY
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 9, pp. 871 - 879
Summary Background The clinical effect of intravesical instillation of chemotherapy immediately after transurethral resection of bladder tumours (TURBT... 
Hematology, Oncology and Palliative Medicine | BACILLUS-CALMETTE-GUERIN | EPIRUBICIN | POSTOPERATIVE INSTILLATION | SINGLE INSTILLATION | ONCOLOGY | TRANSITIONAL-CELL CARCINOMA | DISTILLED WATER | DOUBLE-BLIND | TUMOR | RISK | STAGE-TA | Humans | Middle Aged | Antibiotics, Antineoplastic - adverse effects | Carcinoma - mortality | Male | Urinary Bladder - pathology | Cystectomy - adverse effects | Urothelium - pathology | Time Factors | Urinary Bladder Neoplasms - pathology | Female | Neoadjuvant Therapy | Chemotherapy, Adjuvant | Electrochemotherapy | Urinary Bladder - surgery | Carcinoma - secondary | Carcinoma - drug therapy | Mitomycin - adverse effects | Urinary Bladder Neoplasms - mortality | Risk Assessment | Neoplasm Invasiveness | Carcinoma - surgery | Risk Factors | Neoplasm Recurrence, Local | Proportional Hazards Models | Survival Rate | Treatment Outcome | Urinary Bladder Neoplasms - drug therapy | Urinary Bladder Neoplasms - surgery | Antibiotics, Antineoplastic - administration & dosage | Disease-Free Survival | Survival Analysis | Italy | Urinary Bladder - drug effects | Aged | Administration, Intravesical | Urothelium - surgery | Neoplasm Staging | Urothelium - drug effects | Mitomycin - administration & dosage | Antimitotic agents | Chemotherapy | Care and treatment | Surgery | Antineoplastic agents | Bladder cancer | Cancer
Journal Article
European Urology, ISSN 0302-2838, 2013, Volume 64, Issue 4, pp. 639 - 653
Journal Article